Patrícia A. Possik

Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma

Judith M. Müller, Oscar Krijgsman, Jennifer Tsoi et al. · Nature Communications · 2014 · 621 citations · Full text

Tumor Biology, Oncology, Medicine +10

Abrogation of BRAF^V600E-induced senescence by PI3K pathway activation contributes to melanomagenesis

Liesbeth C.W. Vredeveld, Patrícia A. Possik, Marjon A. Smit et al. · Genes & Development · 2012 · 256 citations · Full text

The Role of BRAF Mutation and p53 Inactivation during Transformation of a Subpopulation of Primary Human Melanocytes

Hong Yu, Ronan McDaid, J. Jack Lee et al. · American Journal Of Pathology · 2009 · 78 citations · Full text

Developmental Biology, Braf Mutation, Cell Division +9

PhosphoPath: Visualization of Phosphosite-centric Dynamics in Temporal Molecular Networks

Linsey M. Raaijmakers, Piero Giansanti, Patrícia A. Possik et al. · Journal of Proteome Research · 2015 · 61 citations · Full text

Biophysical Modeling, Molecular Biology, Cytoskeleton +21

<scp>ROCK</scp> 1 is a potential combinatorial drug target for <scp>BRAF</scp> mutant melanoma

Marjon A. Smit, Gianluca Maddalo, Kylie T. Greig et al. · Molecular Systems Biology · 2014 · 53 citations · Full text